Association analysis of IL7R polymorphisms with inflammatory demyelinating diseases

Kim,Jason Yongha; Cheong,Hyun Sub; Kim,Ho Jin; Kim,Lyoung Hyo; Namgoong,Suhg; Shin,Hyoung Doo

doi:10.3892/mmr.2013.1863

Association analysis of IL7R polymorphisms with inflammatory demyelinating diseases

Authors:
- Jason Yongha Kim
- Hyun Sub Cheong
- Ho Jin Kim
- Lyoung Hyo Kim
- Suhg Namgoong
- Hyoung Doo Shin
View Affiliations

Affiliations: Department of Life Science, Sogang University, Seoul 121742, Republic of Korea, Department of Genetic Epidemiology, SNP Genetics, Inc., Seoul 121742, Republic of Korea, Department of Neurology, National Cancer Center, Ilsandong‑gu, Gyeonggi‑do 410769, Republic of Korea
Published online on: December 13, 2013 https://doi.org/10.3892/mmr.2013.1863
Pages: 737-743

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Multiple sclerosis (MS) and neuromyelitis optica (NMO), which are referred to as inflammatory demyelinating diseases (IDDs), are autoimmune diseases affecting the central nervous system. Interleukin‑7 receptor (IL7R) encodes for a receptor protein that is important in the development of immune cells. Several studies have reported significant associations between IL7R polymorphisms and MS. The aim of the present study was to investigate a possible association between IL7R polymorphisms and IDDs such as MS and NMO. Thirteen single nucleotide polymorphisms (SNPs) were selected based on their linkage disequilibrium (LD), minor allele frequency (MAF) and location, and were genotyped in 178 IDD patients and 237 healthy controls. The association of SNPs with IDD risk was analyzed by logistic regression. A meta‑analysis on the association between rs6897932 and the risk of MS was also performed. Statistical analyses revealed that a common SNP, rs6897932, was marginally associated with IDD in a recessive model (P=0.003, Pcor.=0.03), which had shown significant associations with MS in previous studies. The results replicated the significant association found between rs6897932 and IDD. In addition, the meta‑analysis of rs6897932 clearly demonstrates a higher magnitude of risk in Asian populations than in Caucasian populations. Although there are certain limitations to our study, the results indicate that the genetic variation of IL7R may be associated with IDDs such as MS and NMO in the population studied.

View Figures

View References

1	Compston A and Coles A: Multiple sclerosis. Lancet. 372:1502–1517. 2008. View Article : Google Scholar
2	Kenealy SJ, Pericak-Vance MA and Haines JL: The genetic epidemiology of multiple sclerosis. J Neuroimmunol. 143:7–12. 2003. View Article : Google Scholar
3	Sawcer S, Hellenthal G, Pirinen M, et al: Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 476:214–219. 2011. View Article : Google Scholar : PubMed/NCBI
4	De Jager PL, Jia X, Wang J, et al: Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet. 41:776–782. 2009.PubMed/NCBI
5	Baranzini SE, Wang J, Gibson RA, et al: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet. 18:767–778. 2009. View Article : Google Scholar : PubMed/NCBI
6	Hafler DA, Compston A, Sawcer S, et al: Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 357:851–862. 2007. View Article : Google Scholar : PubMed/NCBI
7	Wingerchuk DM, Hogancamp WF, O’Brien PC and Weinshenker BG: The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 53:1107–1114. 1999.
8	Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF and Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology. 66:1485–1489. 2006. View Article : Google Scholar : PubMed/NCBI
9	Fukazawa T, Yamasaki K, Ito H, et al: Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Tissue Antigens. 55:199–205. 2000. View Article : Google Scholar : PubMed/NCBI
10	Lau KK, Wong LK, Li LS, Chan YW, Li HL and Wong V: Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey. Hong Kong Med J. 8:77–80. 2002.PubMed/NCBI
11	Das A and Puvanendran K: A retrospective review of patients with clinically definite multiple sclerosis. Ann Acad Med Singapore. 27:204–209. 1998.PubMed/NCBI
12	Kim HJ, Park HY, Kim E, et al: Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica. Neurobiol Dis. 37:349–355. 2010. View Article : Google Scholar : PubMed/NCBI
13	Kroemer RT and Richards WG: Homology modeling study of the human interleukin-7 receptor complex. Protein Eng. 9:1135–1142. 1996. View Article : Google Scholar : PubMed/NCBI
14	Xue HH, Bollenbacher J, Rovella V, et al: GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells. Nat Immunol. 5:1036–1044. 2004. View Article : Google Scholar : PubMed/NCBI
15	Alcina A, Fedetz M, Ndagire D, et al: The T244I variant of the interleukin-7 receptor-alpha gene and multiple sclerosis. Tissue Antigens. 72:158–161. 2008. View Article : Google Scholar : PubMed/NCBI
16	Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet. 41:824–828. 2009. View Article : Google Scholar : PubMed/NCBI
17	Fang L, Isobe N, Yoshimura S, et al: Interleukin-7 receptor alpha gene polymorphism influences multiple sclerosis risk in Asians. Neurology. 76:2125–2127. 2011. View Article : Google Scholar : PubMed/NCBI
18	Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1444–1452. 1983. View Article : Google Scholar : PubMed/NCBI
19	Barrett JC, Fry B, Maller J and Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21:263–265. 2005. View Article : Google Scholar : PubMed/NCBI
20	Stephens M, Smith NJ and Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 68:978–989. 2001. View Article : Google Scholar : PubMed/NCBI
21	Weber F, Fontaine B, Cournu-Rebeix I, et al: IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun. 9:259–263. 2008. View Article : Google Scholar : PubMed/NCBI
22	Rubio JP, Stankovich J, Field J, et al: Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun. 9:624–630. 2008. View Article : Google Scholar : PubMed/NCBI
23	Akkad DA, Hoffjan S, Petrasch-Parwez E, Beygo J, Gold R and Epplen JT: Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients. J Autoimmun. 32:110–115. 2009. View Article : Google Scholar : PubMed/NCBI
24	Sombekke MH, van der Voort LF, Kragt JJ, et al: Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis. Mult Scler. 17:922–930. 2011. View Article : Google Scholar : PubMed/NCBI
25	O’Doherty C, Kantarci O and Vandenbroeck K: IL7RA polymorphisms and susceptibility to multiple sclerosis. N Engl J Med. 358:753–754. 2008.PubMed/NCBI
26	Lundmark F, Duvefelt K, Iacobaeus E, et al: Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet. 39:1108–1113. 2007. View Article : Google Scholar : PubMed/NCBI
27	Kallio SP, Jakkula E, Purcell S, et al: Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS. Hum Mol Genet. 18:1670–1683. 2009. View Article : Google Scholar : PubMed/NCBI
28	Gregory SG, Schmidt S, Seth P, et al: Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet. 39:1083–1091. 2007. View Article : Google Scholar : PubMed/NCBI
29	Ramagopalan SV, Anderson C, Sadovnick AD and Ebers GC: Genomewide study of multiple sclerosis. N Engl J Med. 357:21992–200. 2007.